Filter
706
Filtered Results: 706
Text search:
pharmaceutical
quality
control
laboratories
Featured
Recommendations
78
New Publications
217
Language
Document type
No document type
360
Studies & Reports
131
Guidelines
114
Strategic & Response Plan
48
Manuals
36
Training Material
7
Situation Updates
6
Fact sheets
3
Resource Platforms
1
Countries / Regions
India
43
Kenya
33
Ethiopia
29
Nigeria
18
Western and Central Europe
17
South Africa
17
Sierra Leone
15
Uganda
15
Ghana
14
Nepal
13
Global
13
Bangladesh
13
Liberia
13
Malawi
12
Philippines
11
Tanzania
11
Africa
10
Eastern Europe
10
Rwanda
9
Cambodia
9
Zambia
9
Ukraine
7
Senegal
6
Burkina Faso
6
Zimbabwe
6
South–East Asia Region
6
Namibia
6
Myanmar / Burma
6
Syria
5
Latin America and the Carribbean
5
Eswatini/ Swaziland
5
Thailand
4
Lesotho
4
Benin
4
Haiti
4
Botswana
4
Indonesia
4
Cameroon
3
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Pakistan
3
Albania
2
Laos
2
Guinea
2
USA
2
Asia
2
Venezuela
2
Western Pacific Region
2
Vietnam
2
Madagascar
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Peru
1
Mozambique
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
Gabon
1
Turkmenistan
1
France
1
Maldives
1
Papua New Guinea
1
Moldova
1
Sudan
1
Yemen
1
Mali
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
335
Clinical Guidelines
39
Key Resources
35
Public Health
21
Pharmacy & Technologies
21
Women & Child Health
13
Capacity Building
3
Toolboxes
AMR
122
Pharmacy
55
COVID-19
54
TB
47
Rapid Response
36
NTDs
22
HIV
18
Mental Health
16
Planetary Health
11
Conflict
10
Health Financing Toolbox
9
Caregiver
8
Polio
8
Ebola & Marburg
6
Global Health Education
6
Specific Hazards
5
Natural Hazards
4
NCDs
4
Refugee
3
Cholera
3
Zika
2
Mission report: June 11-20, 2017
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
Building laboratory testing capacity
These guidelines are applicable to all biomedical, social and behavioural science research for health conducted in India involving human participants, their biological material and data.
The purpose of such research should be: i. directed towards enhancing knowledge about the human condition while ...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
16-24 February 2020
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
guidance for health managers, health workers, and activists
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T...
